1 |
7.3 |
Improving efforts (e.g., funding) towards developing novel technologies innovations focused on facilitating appropriate medication prescribing and/or deprescribing in older adults living with frailty. |
2 |
6.5 |
Increasing research into developing or improving models that facilitate pharmacists playing an active role in the process of monitoring and assessing use of potentially inappropriate medications. |
2 |
6.5 |
Further research into the values and preferences held by elderly patients living with frailty with respect to medication use (e.g., determine perspectives regarding appropriate medication prescription or deprescribing). |
3 |
6.4 |
Building an (electronic) system and practice system so that a patient’s medications can be monitored and reviewed in real time to determine the current need and appropriateness of each medication, as well as potential for adverse drug–drug interactions. |
3 |
6.4 |
Advocacy for clinical trials that specifically evaluate the therapeutic benefit and adverse effects of new and current medications on seniors living with frailty. [merged and edited] |
4 |
6.2 |
New innovations being developed so that patients (and their trained care providers) are empowered to monitor and assess their own medication use. |
5 |
4.9 |
Promoting and supporting the development of a nation-wide Pharmacare plan for all Canadians. |